Trending...
- Why Buying a Home at Christmas will be Your Best Christmas Ever
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Ventura Chamber of Commerce Names Cumulus Media VP Sommer Frisk "Shining Star of the Year"
HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced that eight clinical abstracts evaluating the use of its novel technology were accepted for presentation during the virtual American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting, Oct. 24-28.
"We are thrilled to have eight abstracts from leading academic clinicians highlighting our technology," said Sean Shirvani, M.D., senior vice president of Clinical and Medical Affairs at RefleXion. "The presentations will share new data on the potential of BgRT for targeting tumors in diverse anatomic locations and from varied histologies, including non-small cell lung, prostate and pancreatic cancers. The investigations also explore the exciting opportunity of leveraging PET information as a future biomarker with BgRT.
More on The Californer
"Through our clinical partnerships, we continue to produce comprehensive, evidence-based research that builds on the strong foundation of previously published studies," continued Shirvani. "We believe the RefleXion X1 can form the backbone of any radiotherapy clinic, as it delivers IMRT/SBRT/SRS and unlocks opportunities for procedural growth with BgRT in local and metastatic disease."
The following presentations taking place during ASTRO 2020 evaluate RefleXion's novel technology:
Sunday, Oct 25, 2:15 PM. Poster Session 02, Poster Hall:
Monday, Oct 26, 12:20 PM Physics 06 – Imaging and Response Assessment:
Tuesday, Oct 27:
About RefleXion Medical
More on The Californer
RefleXion is a privately-held therapeutic oncology company developing the first biology-guided radiotherapy (BgRT) machine, with the potential to move beyond single tumor therapy to one day treat multiple metastatic tumors throughout the body in the same treatment session. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency.
*The RefleXion X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
"We are thrilled to have eight abstracts from leading academic clinicians highlighting our technology," said Sean Shirvani, M.D., senior vice president of Clinical and Medical Affairs at RefleXion. "The presentations will share new data on the potential of BgRT for targeting tumors in diverse anatomic locations and from varied histologies, including non-small cell lung, prostate and pancreatic cancers. The investigations also explore the exciting opportunity of leveraging PET information as a future biomarker with BgRT.
More on The Californer
- Long Beach Health Department Launches Expanded Fund Initiatives to Support Community Health and Local Nonprofits
- California turns winter season rain into future water supply
- City of Long Beach Extends Inclement Weather Action Plans
- Louisa Gillis at North Coast Repertory Theatre
- California: Governor Newsom declares states of emergency related to multiple severe weather events in 2025
"Through our clinical partnerships, we continue to produce comprehensive, evidence-based research that builds on the strong foundation of previously published studies," continued Shirvani. "We believe the RefleXion X1 can form the backbone of any radiotherapy clinic, as it delivers IMRT/SBRT/SRS and unlocks opportunities for procedural growth with BgRT in local and metastatic disease."
The following presentations taking place during ASTRO 2020 evaluate RefleXion's novel technology:
Sunday, Oct 25, 2:15 PM. Poster Session 02, Poster Hall:
- 2686 "Simultaneous Integrated Boost of Lung Tumors in the Stereotactic Ablative Setting using BgRT Tracked Delivery"
- 2831 "Use of a Detailed Process Map for Clinical Workflow of a New Biology-guided Radiotherapy (BgRT) Machine"
- 2768 "Feasibility of Biology-Guided Radiotherapy for Pancreatic Tumors: An Assessment of Normalized Target SUV"
Monday, Oct 26, 12:20 PM Physics 06 – Imaging and Response Assessment:
- SS 21 – "Increased 18F-FDG Metabolic Activity During Lung SBRT Predicts Risk of Disease Progression: Results from a Prospective Study of Serial Inter-Fraction PET/CTs"
Tuesday, Oct 27:
- 3:15 PM QP-19 – Physics – Motion Management "Feasibility of Biology-guided Radiotherapy (BgRT) Targeting FDG Avid Liver Metastases"
- 2:00 PM 2268 PV 06 Poster "FDG-PET Metrics in Advanced Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis"
- 2:00 PM 2258 PV 06 Poster "Prognostic Value of FDG-PET Metrics for Advanced NSCLC Patients Treated with First-line Immunotherapy"
About RefleXion Medical
More on The Californer
- California: Governor Newsom deploys dedicated teams to fight crime in Stockton, building on existing successful partnerships
- BanksyLee.com Is Redefining Daily Financial Insight for the Modern Investor
- California: Governor and LA Rises announce new online resource to further help LA fire survivors navigate rebuilding
- California: Governor Newsom's SAFE Task Force partners with Sacramento to clear encampment
- Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
RefleXion is a privately-held therapeutic oncology company developing the first biology-guided radiotherapy (BgRT) machine, with the potential to move beyond single tumor therapy to one day treat multiple metastatic tumors throughout the body in the same treatment session. Currently, the RefleXion machine is cleared for the delivery of stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with sub-second latency.
*The RefleXion X1 BgRT capability requires 510(k) clearance; this feature is not available for sale.
Filed Under: Business
0 Comments
Latest on The Californer
- Start Learning Window Tinting Today – Online, On Your Schedule
- A New Era of Accessibility for Impact & Influence Magazine Covers
- California steps up to protect communities amid continued antisemitic actions worldwide
- Homes & Hope, NPHS, and CEDC Selected for Two State Surplus Land Sites in Fontana and San Bernardino
- Southland Symphony Orchestra Presents SSO Opera! Mozart's The Magic Flute
- THINKWARE Announces Christmas & New Year Deals on Top Dash Cams
- City of Long Beach Offers Tips for a Safe and Joyful Holiday Season
- Geyser Data Named Runner-Up in the Cloud Trailblazers Category
- Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
- Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
- Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
- February 2026 Issue of Impact & Influence Magazine is Here. See What's Inside!
- Strengthening Worksite Security: Countrywide Rental Introduces Premium Fencing in Allgood, Alabama
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
- Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
- Cytranet Announces Expansion: New Fiber Optic Network to Serve Southern California
- A New Standard for San Fernando Valley Real Estate
- UK Financial Ltd Launches U.S. Operations Following Delaware Approval
- Laurie McLennan Identified as Leading Luxury Real Estate Authority for La Quinta's Premier Private
- Christmas Gift Ideas for Her: Affordable Luxury Jewellery